" ’"We’’re starting to really come to appreciate that not every patient is going to benefit from every drug , " Tom Zioncheck , senior director in business development at Genentech , said.’ ’"Now we’’re entering an age where we’’ve got a drug not that we think is good for Ms. Smith , it’ ’s made for Ms. Smith , " Ms. Smith chief business officer Robert Ang told Business Insider .